Generic versions of common epilepsy, bipolar drug to be released soon

07/30/2008 | Bloomberg

Eight drug manufacturers have been approved to market a generic version of Depakote DR, a delayed-release treatment for epilepsy, bipolar disorder and migraines. The generic treatments will have the same safety label as the brand-name version, including a warning about the risk of death from liver injury or pancreas inflammation.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
School Improvement Officer
Kent School District
Kent, WA
Account Executive - Central Region
NWEA
Multiple Locations, SL_Multiple Locations
Account Manager
NWEA
Multiple Locations, SL_Multiple Locations
School Reading Coaches
Rowland Reading Foundation
Multiple Locations, SL_Multiple Locations
Elementary School Principal
Kent School District
Kent, WA